Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 2.240
-0.020 (-0.88%)
Mar 2, 2026, 10:57 AM AEST
-31.50% (1Y)
| Market Cap | 429.09M |
| Revenue (ttm) | 737.49M |
| Net Income (ttm) | 26.31M |
| Shares Out | 189.86M |
| EPS (ttm) | 0.14 |
| PE Ratio | 16.03 |
| Forward PE | 12.94 |
| Dividend | 0.13 (5.53%) |
| Ex-Dividend Date | Mar 12, 2026 |
| Volume | 43,995 |
| Average Volume | 1,039,276 |
| Open | 2.260 |
| Previous Close | 2.260 |
| Day's Range | 2.230 - 2.260 |
| 52-Week Range | 2.080 - 3.410 |
| Beta | 1.01 |
| RSI | 39.12 |
| Earnings Date | Feb 16, 2026 |